Inhatarget Therapeutics: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Inhatarget Therapeutics
Largest movements
- Current investments -€850,000
down €850,000 (-48.6%), from €1.8m to €900,000
- Intangible fixed assets +€73,518
up €73,518 (+26.0%), from €283,298 to €356,817
- Contributions -€1.5m
down €1.5m (-37.9%), from €3.8m to €2.4m
- Profit (loss) carried forward +€834,028
up €834,028 (+47.5%), from -€1.8m to -€921,288
- Other debts -€132,208
down €132,208 (-25.7%), from €514,389 to €382,181
- Trade debts -€72,383
down €72,383 (-32.6%), from €222,205 to €149,822
- Gross operating margin +€165,210
up €165,210 (+247%), from €66,753 to €231,962
- Taxes +€104,597
up €104,597, from -€104,248 to €349
- Financial income -€89,582
down €89,582 (-8.0%), from €1.1m to €1.0m
- Depreciation +€81,425
up €81,425 (+4.7%), from €1.7m to €1.8m
- Staff costs -€21,175
down €21,175 (-5.3%), from €397,617 to €376,442
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,957,294 | €2,156,542 | -€800,752 | -27.1% |
| Fixed assets | 21/28 | €288,276 | €359,608 | +€71,333 | +24.7% |
| Intangible fixed assets | 21 | €283,298 | €356,817 | +€73,518 | +26.0% |
| Tangible fixed assets | 22/27 | €4,527 | €2,642 | -€1,885 | -41.6% |
| Plant, machinery and equipment | 23 | €3,302 | €1,656 | -€1,646 | -49.8% |
| Furniture and vehicles | 24 | €1,225 | €986 | -€239 | -19.5% |
| Financial fixed assets | 28 | €450 | €150 | -€300 | -66.7% |
| Current assets | 29/58 | €2,669,018 | €1,796,934 | -€872,085 | -32.7% |
| Amounts receivable within one year | 40/41 | €229,061 | €219,163 | -€9,898 | -4.3% |
| Trade receivables | 40 | - | €5,287 | +€5,287 | |
| Other amounts receivable | 41 | €229,061 | €213,876 | -€15,185 | -6.6% |
| Current investments | 50/53 | €1,750,000 | €900,000 | -€850,000 | -48.6% |
| Cash at bank and in hand | 54/58 | €675,737 | €669,909 | -€5,828 | -0.9% |
| Deferred charges and accrued income | 490/1 | €14,220 | €7,861 | -€6,359 | -44.7% |
| Total equity and liabilities | 10/49 | €2,957,294 | €2,156,542 | -€800,752 | -27.1% |
| Equity | 10/15 | €2,164,146 | €1,568,763 | -€595,383 | -27.5% |
| Contributions | 10/11 | €3,841,162 | €2,386,087 | -€1.5m | -37.9% |
| Profit (loss) carried forward | 14 | -€1,755,317 | -€921,288 | +€834,028 | +47.5% |
| Investment grants | 15 | €78,301 | €103,965 | +€25,664 | +32.8% |
| Amounts payable | 17/49 | €793,147 | €587,779 | -€205,369 | -25.9% |
| Amounts payable within one year | 42/48 | €791,076 | €585,835 | -€205,241 | -25.9% |
| Trade debts | 44 | €222,205 | €149,822 | -€72,383 | -32.6% |
| Suppliers | 440/4 | €222,205 | €149,822 | -€72,383 | -32.6% |
| Taxes, remuneration and social security | 45 | €54,483 | €53,833 | -€650 | -1.2% |
| Remuneration and social security | 454/9 | €54,483 | €53,833 | -€650 | -1.2% |
| Other amounts payable | 47/48 | €514,389 | €382,181 | -€132,208 | -25.7% |
| Accrued charges and deferred income | 492/3 | €2,071 | €1,944 | -€127 | -6.2% |
| Remuneration, social security and pensions | 62 | €397,617 | €376,442 | -€21,175 | -5.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,716,296 | €1,797,720 | +€81,425 | +4.7% |
| Other operating charges | 640/8 | €1,099 | €1,105 | +€6 | +0.6% |
| Gross operating margin | 9900 | €66,753 | €231,962 | +€165,210 | +247% |
| Operating profit (loss) | 9901 | -€2,048,259 | -€1,943,305 | +€104,954 | +5.1% |
| Financial income | 75/76B | €1,114,594 | €1,025,013 | -€89,582 | -8.0% |
| Recurring financial income | 75 | €1,114,594 | €1,025,013 | -€89,582 | -8.0% |
| Financial charges | 65/66B | €3,219 | €2,646 | -€573 | -17.8% |
| Recurring financial charges | 65 | €3,219 | €2,646 | -€573 | -17.8% |
| Profit (loss) for the period before taxes | 9903 | -€936,884 | -€920,939 | +€15,945 | +1.7% |
| Income taxes | 67/77 | -€104,248 | €349 | +€104,597 | |
| Profit (loss) for the period | 9904 | -€832,636 | -€921,288 | -€88,652 | -10.6% |
| Profit (loss) for the period to be appropriated | 9905 | -€832,636 | -€921,288 | -€88,652 | -10.6% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 27 October 2026 via checked.be.